New Treatments for Crack-Cocaine Dependence in the Netherlands
Author Information
Author(s): Mascha Nuijten, Peter Blanken, Wim van den Brink, Vincent Hendriks
Primary Institution: Parnassia Addiction Research Centre (PARC, Brijder Addiction Treatment)
Hypothesis
The study investigates the effectiveness of new pharmacological treatments for crack-cocaine dependence.
Conclusion
The CATCH study aims to explore new treatment options for crack-cocaine dependence, focusing on both abstinence and harm minimization.
Supporting Evidence
- The study is the first in the Netherlands to explore new treatment options for crack-cocaine dependence.
- Topiramate, modafinil, and dexamphetamine SR are being tested for their effectiveness.
- The study aims to improve treatment retention and patient satisfaction.
Takeaway
This study is trying to find better ways to help people who are addicted to crack cocaine by testing new medications along with therapy.
Methodology
The study consists of three randomized controlled trials comparing new medications with cognitive behavioral therapy.
Potential Biases
The open-label design may introduce bias as participants are aware of their treatment assignment.
Limitations
Control patients will not receive placebo, and there may be experimenter bias due to the open-label design.
Participant Demographics
Participants are cocaine dependent adults, primarily using crack cocaine, aged 18 and older.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website